Now showing items 1-1 of 1

    • Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation 

      Freeman, James V.; Zhu, Ruo P.; Owens, Douglas K.; Garber, Alan M; Hutton, David W.; Go, Alan S.; Wang, Paul J.; Turakhia, Mintu P. (American College of Physicians, 2011)
      Background: Warfarin reduces the risk for ischemic stroke in patients with atrial fibrillation (AF) but increases the risk for hemorrhage. Dabigatran is a fixed-dose, oral direct thrombin inhibitor with similar or reduced ...